Generic-Pill Spending Dips in ‘Fierce’ U.S. Price War (Update3)
Dec. 10 (Bloomberg) -- American consumers and health
insurers saved about $1 billion on generic drugs this year as
“fierce” competition among drugmakers and pressure from
insurers lowered prices.
,
and other generic-drug makers fell 2.7 percent
to $33 billion in the 12 months ended in September, the biggest
decline in at least a decade, the health research firm
today. The average price manufacturers
charged wholesalers for the copycat pills fell 8 percent while
demand increased 5.4 percent, IMS said.
The surge in Continue reading